2015 Lipper Award Logo

Relentless About Delivering
Great Results for Our Clients

2015 Lipper
Awards

We’re proud to recognize Janus Balanced Fund and Janus Contrarian Fund for their proven ability to deliver strong risk-adjusted returns for our investors.

Barron’s recognizes the Janus Contrarian Fund as a “high-profile fund” that is “back on a market-beating course.” (4/4/2015)

Newly Reopened: A Risk-Conscious Small-Cap Fund — Morningstar (1/22/2015)

Andy Acker, PM of the Janus Global Life Sciences Fund, discusses his views in Fortune's article "The Science of Making Money in Biotech." (3/15/2015)

New York Times applauds Janus Venture Fund PMs Jonathan Coleman and Maneesh Modi for incorporating both growth and value in stock-picking.

Named Best Mixed-Asset Target Allocation Moderate Fund over ten years (Class D shares)*

 Overall Morningstar Rating™
(as of 03/31/2015), Class D Shares, among 787 Moderate Allocation Funds.

FIND MY SALES DIRECTOR

Enter your ZIP code to get contact information for the wholesaler in your region.

ENTER ZIP:
SUBMIT   

If you are an RIA: CONTACT RIA GROUP

PORTFOLIO ANALYSIS TOOL

Test and analyze portfolio weaknesses and strengths with our Fund vs. Fund, Portfolio Analysis and Portfolio Comparison tools powered by Morningstar.

UPCOMING CONFERENCE CALLS

Building Meaningful Relationships with CPAs featuring John Evans Jr., Executive Director of Janus Labs & John Kuttin, Barron's top 100 advisor of 2014, CEO of Kuttin Consulting Group